ARKK vs BVS
ARK Innovation ETF (ARKK) versus Bioventus Inc (BVS) — a side-by-side from cached financials, not a winner call.
ARK Innovation ETF (ARKK) common stock listed on US.
Bioventus Inc (BVS) is a medical devices company listed on US.
ARKK does not have a complete income-statement cache yet.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
ARKK currently screens at market cap $0. BVS currently screens at market cap $495.1M.
Not investment advice. Open the ARKK and BVS stock pages for the full models.
Not investment advice.